Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Soo steel investment: a win for workers and the community | Investissement à Sault Ste. Marie : une victoire pour les travailleurs et la communauté
-
New York City, NY, May 22, 2026 (GLOBE NEWSWIRE) -- Neuro Salt is rapidly emerging as one of the most talked-about nerve health dietary supplements of 2026, as consumer demand for natural...
-
Agreement covers 6,000 airport and customer service employees MONTREAL, May 22, 2026 (GLOBE NEWSWIRE) -- Air Canada today said it has reached a tentative collective agreement with Unifor,...
-
New York, NY, May 22, 2026 (GLOBE NEWSWIRE) -- BTC Ecosystem today announced a new strategic initiative involving AntPool and Bitmain, marking a significant development in the global Bitcoin...
-
JERSEY CITY, N.J., May 22, 2026 (GLOBE NEWSWIRE) -- Moomoo, a leading global investment and trading platform that empowers self-directed investors with advanced market data and professional-grade...
-
Austin, United States, May 22, 2026 (GLOBE NEWSWIRE) -- “SNS Insider reported that global Vascular Closure Devices Market was valued at USD 1.92 billion in 2025 and is projected to reach USD 4.08...
-
NOT FOR DISSEMINATION INTO THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES TORONTO and HOUSTON, May 22, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the...
-
TORONTO, May 22, 2026 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that Royal Columbian Hospital (RCH) has dosed its first...
-
CROSSJECT announces the successful completion of an equity financing and warrant issuance for a total immediate gross amount of €15 million
-
VANCOUVER, British Columbia, May 21, 2026 (GLOBE NEWSWIRE) -- NervGen Pharma Corp. (“NervGen” or the “Company") (NASDAQ: NGEN), a clinical-stage biopharmaceutical company developing first-in-class...